Guardant Health Inc reports results for the quarter ended June 30 - Earnings Summary

Guardant Health

31/07/2026 08:36

Guardant Health Inc GH.OQ reported a quarterly adjusted loss of 42 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -80 cents.  The mean expectation of twenty three analysts for the quarter was for a loss of 41 cents per share. Wall Street expected results to range from -71 cents to -21 cents per share.
Revenue rose 48.6% to $344.98 million from a year ago; analysts expected $314.23 million. 
Guardant Health Inc's reported EPS for the quarter was a loss of 90 cents​.
The company reported a quarterly loss of $120.14 million.
Guardant Health Inc shares had risen by 1.5% this quarter and gained 49.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 16.3% in the last three months.​ 
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 25 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for Guardant Health Inc is $180.00, about 15.4% above its last closing price of $152.35
This summary was machine generated from LSEG data July 31 at 07:36 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.41
-0.42
Missed
Mar. 31 2026 
-0.50
-0.45
Beat
Dec. 31 2025 
-0.70
-1.00
Missed
Sep. 30 2025 
-0.70
-0.74
Missed